News & Events
-
August 29, 2023
Externally-Led Patient Focused Drug Development
C-Path’s Polycystic Kidney Disease Outcomes Consortium (PKDOC) and the PKD Foundation will be hosting an Externally-Led Patient Focused Drug Development (EL-PFDD) meeting for Autosomal Recessive Polycystic Kidney Disease (ARPKD) on Tuesday, August 29th. EL-PFDD meetings bring together patients and care partners, US Food and Drug Administration (FDA) representatives, pharmaceutical companies, physicians, and researchers who are...... -
May 19, 2021 - May 20, 2021
View Now | 2021 PKD Regulatory Summit | May 19-20
Join C-Path’s PKDOC and The PKD Foundation for the 2021 PKD Regulatory Summit on May 19 and 20. Together with key stakeholders from around the world, the consortium will address current unmet drug development needs for PKD, identify tools that are needed to deliver new therapies to patients, and catalyze the development of a regulatory framework to enable advancement of new treatments.
-
September 9, 2019 - September 10, 2019
Solutions to Drug Development Challenges Workshop: Utilizing Quantitative Approaches, Data Sharing, and Novel Biomarkers
Title Presenter Presentation Link Introduction Dr. John-Michael Sauer (C-Path) Keynote Address Dr. Joseph Scheeren (C-Path) Welcoming Remarks Dr. Janet Woodcock (US FDA) Session 2: Benefits of DDT progression to regulatory acceptance Moderators: Dr. Inish O’Doherty (C-Path) and Dr. Ameeta Parekh (US FDA) 2.1 A perspective on the history and evolution of drug development...... - July 14, 2016